These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 693524)

  • 1. Cyclophosphamide chemotherapy of intrapulmonarily implanted Lewis lung carcinoma.
    Ho W; Furst A
    Proc West Pharmacol Soc; 1978; 21():397-400. PubMed ID: 693524
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hemostasis modifiers of the activity of VP 16 213 on Lewis lung carcinoma.
    Cattan A; Pourny C; Carpentier Y; Cattan E; Barouh M
    Biomedicine; 1977 Jul; 27(5):203-8. PubMed ID: 922120
    [No Abstract]   [Full Text] [Related]  

  • 4. Biologic characterization of the subcutaneously implanted Lewis lung tumor.
    Mayo JG
    Cancer Chemother Rep 2; 1972 Nov; 3(1):325-30. PubMed ID: 4660735
    [No Abstract]   [Full Text] [Related]  

  • 5. Stem-cell survival and tumor control in the Lewis lung carcinoma.
    Steel GG; Adams K
    Cancer Res; 1975 Jun; 35(6):1530-5. PubMed ID: 1169108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotational stress reduces the effectiveness of antitumor drugs in mice.
    Giraldi T; Perissin L; Zorzet S; Rapozzi V
    Ann N Y Acad Sci; 1994 Nov; 741():234-43. PubMed ID: 7825811
    [No Abstract]   [Full Text] [Related]  

  • 7. Lewis lung carcinoma in mice as an experimental therapy model. II. The effect of BCNU, cyclophosphamide and/or surgery treatment on early and advanced tumor in mice.
    Budzyński W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):373-7. PubMed ID: 7184488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A semisynthetic flavonoid from the Baikal skullcap (Scutellaria baicalensis) as an agent to enhance the efficacy of chemotherapy in experimental tumors].
    Razina TG; Zueva EP; Litvinenko VI; Kovalev IP
    Eksp Klin Farmakol; 1998; 61(2):54-6. PubMed ID: 9621177
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
    Wietrzyk J; Opolski A; Madej J; Radzikowski C
    In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of Lewis lung carcinoma by combined treatment with local hyperthermia and cyclophosphamide: preliminary results.
    Yerushalmi A; Hazan G
    Isr J Med Sci; 1979 May; 15(5):462-3. PubMed ID: 447517
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic response of human lung tumour xenografts to cyclophosphamide.
    Mattern J; Jaeger S; Wayss K; Volm M
    Anticancer Res; 1982; 2(6):355-8. PubMed ID: 7168553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative model for the study of the growth and treatment of a tumor and its metastases with correlation between proliferative state and sensitivity to cyclophosphamide.
    DeWys WD
    Cancer Res; 1972 Feb; 32(2):367-73. PubMed ID: 5058192
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of oxalysine on pulmonary metastases of Lewis lung carcinoma in mice].
    Yue XF; Wu FG; Xu B
    Zhongguo Yao Li Xue Bao; 1985 Sep; 6(3):198-200. PubMed ID: 2943127
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of tranexamic acid and urokinase on hematogenous metastases of Lewis lung carcinoma in mice.
    Tanaka N; Ogawa H; Tanaka K; Kinjo M; Kohga S
    Invasion Metastasis; 1981; 1(3):149-57. PubMed ID: 7188385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the content and composition of gangliosides of tumors as affected by chemotherapeutic agents].
    Kozlov AM; Novikov AM; Bassalyk LS; Sof'ina ZP
    Eksp Onkol; 1984; 6(5):62-6. PubMed ID: 6510346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant interleukin-1 alpha, recombinant interleukin-2, recombinant interferon-beta, and recombinant tumor necrosis factor on subcutaneously implanted adenocarcinoma 755 and Lewis lung carcinoma.
    Iigo M; Nishikata K; Hoshi A
    J Biol Response Mod; 1990 Aug; 9(4):426-30. PubMed ID: 2395006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy with anticancer agents and OK-432.
    Kimura I; Onoshi T; Takano J; Osawa H; Yasuhara S
    Acta Med Okayama; 1974 Dec; 28(6):411-21. PubMed ID: 4142360
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
    Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
    Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of surgery, chemotherapy and immunotherapy on Lewis lung tumour.
    Thompson RB; Alberola V; Mathé G
    Rev Eur Etud Clin Biol; 1972 Nov; 17(9):900-2. PubMed ID: 4653992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.